Dina R. Mody, MD

Professor of Pathology and Genomic Medicine, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


After completing her postdoctoral training, Dr. Mody joined the faculty at the Baylor College of Medicine in Houston, Texas as an Instructor of Pathology in 1984. She received her full professorship there in 2000, and held the Ibrahim Ramzy Endowed Chair. In 2007-2008, Dr. Mody served as President of the American Society of Cytopathology (ASC). She has given numerous workshops, teleconferences, symposia and lectures at its national meetings. She has also served on the ASC Executive Board, Chaired the Scientific Program Committee and chaired the Quality Assurance Committee. She co-chaired the Practice Guidelines Committee, which developed the Cervical Cytology Practice Guidelines for which she received the President’s Award of the ASC in 1999. In 2002, she received the Lansky Award of the College of American Pathologists (CAP) for her leadership role in cytology, and has served as Chair of the CAP Cytopathology Resource Committee. From 2004-08, Dr. Mody was appointed to the Clinical Laboratory Improvement Advisory Committee (CLIAC) of the CDC, where she served as an advisor on cytology issues to the CDC and CMS. Previous leadership positions include President of the Texas Society of Cytology, and Chair of Scientific Program of the Houston Society of Clinical Pathologists. In 2014 she published an 800+ page text book: Diagnostic Pathology Cytopathology. She is currently the Editor-in-Chief of The Journal of the American Society of Cytopathology.

Description of Research

Dr. Mody’s previous research interests have been in the area of glandular lesions in cervicovaginal cytology and pathology, as well as bone and soft tissue cytology and pathology. Her early papers on tissue and bone reactions to implants were instrumental to the defense when reactions to breast implants were the subject of major litigation in the United States. Dr. Mody’s current research focuses on the application of HPV testing and genotyping in low- and high-risk populations, application of new imaging modalities to diagnostic cytopathology, and immunohistochemical and molecular testing in cytology.

Areas Of Expertise

Fine needle aspiration cytology Gynecologic, bone, and soft tissue cytology HPV testing and genotyping
Education & Training

Residency, Baylor College of Medicine
Internship, K.E.M. Hospital
MD, Bombay University, Seth GS Medical College

Pathology Trainee Redeployment and Education During the COVID-19 Pandemic: An Institutional Experience
Monroig-Bosque, PDC, Hsu, JW, Lin, MS, Shehabeldin, AN, Rogers, JT, Kim, CF, Kalsekar, AG, Jin, Z, Cara, LR, Barbieri, AN, El-Zaatari, Z, Eskandari, G, Sheu, TG, Tomsula, JA, Long, SW, Zieske, AW, Leveque, CM, Salazar, E, Mody, DR, Schwartz, MR, Cykowski, MD, Yi, X, Powell, SZ & Thomas, JS 2020, , Academic Pathology, vol. 7. https://doi.org/10.1177/2374289520953548

Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting
Ge, Y, Christensen, PA, Luna, E, Armylagos, D, Xu, J, Hsu, JW, Zhou, H, Schwartz, MR & Mody, DR 2019, , Cancer cytopathology, vol. 127, no. 12, pp. 757-764. https://doi.org/10.1002/cncy.22192

HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests
Ge, Y, Mody, RR, Olsen, RJ, Zhou, H, Luna, E, Armylagos, D, Puntachart, N, Hendrickson, H, Schwartz, MR & Mody, DR 2019, , Journal of the American Society of Cytopathology, vol. 8, no. 3, pp. 149-156. https://doi.org/10.1016/j.jasc.2019.01.001

Role of HPV genotyping in risk assessment among cytology diagnosis categories: Analysis of 4562 cases with cytology-HPV cotesting and follow-up biopsies
Ge, Y, Christensen, P, Luna, E, Armylagos, D, Xu, J, Schwartz, MR & Mody, DR 2019, , International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol. 29, no. 2, pp. 234-241. https://doi.org/10.1136/ijgc-2018-000024

Bethesda 2014 implementation and human papillomavirus primary screening practices of laboratories participating in the College of American Pathologists PAP education program
Davey, DD, Souers, RJ, Goodrich, K, Mody, DR, Tabbara, SO & Booth, CN 2019, , Archives of Pathology and Laboratory Medicine, vol. 143, no. 10, pp. 1196-1202. https://doi.org/10.5858/arpa.2018-0603-CP

Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections
Austin, RM, Zhao, C & Mody, DR 2018, , Obstetrics and Gynecology, vol. 132, no. 3. https://doi.org/10.1097/AOG.0000000000002824

Aptima Human Papillomavirus E6/E7 mRNA Test Results Strongly Associated with Risk for High-Grade Cervical Lesions in Follow-Up Biopsies
Ge, Y, Christensen, P, Luna, E, Armylagos, D, Xu, J, Schwartz, MR & Mody, DR 2018, , Journal of Lower Genital Tract Disease, vol. 22, no. 3, pp. 195-200. https://doi.org/10.1097/LGT.0000000000000393

Negative Pap tests in women with high-grade cervical lesions on follow-up biopsies: Contributing factors and role of human papillomavirus genotyping
Goodman, S, Mody, RR, Coffey, D, Gorman, B, Luna, E, Armylagos, D, Schwartz, MR, Mody, DR & Ge, Y 2018, , Diagnostic Cytopathology, vol. 46, no. 3, pp. 239-243. https://doi.org/10.1002/dc.23874

Laboratory management curriculum for cytopathology subspecialty training
Nayar, R, Barkan, GA, Benedict, C, Booth, C, Chhieng, DC, Mody, D, Siddiqui, MT, Tabatabai, LZ & Johnson, R 2018, , Journal of the American Society of Cytopathology, vol. 7, no. 2, pp. 61-78. https://doi.org/10.1016/j.jasc.2017.12.003

Next-generation sequencing identifies gene mutations that are predictive of malignancy in residual needle rinses collected from fine-needle aspirations of thyroid nodules
Fuller, MY, Mody, D, Hull, A, Pepper, K, Hendrickson, H & Olsen, R 2018, , Archives of Pathology and Laboratory Medicine, vol. 142, no. 2, pp. 178-183. https://doi.org/10.5858/arpa.2017-0136-OA

Bone and Cartilage
Mody, DR & Ramzy, I 2018, . in I Ramzy, D Mody & R Laucirica (eds), Clinical Cytopathology: Fundamental Principles and Practice. 3rd edn, McGraw Hill Education, pp. 631-646.

Do infection patterns of human papillomavirus affect the cytologic detection of high-grade cervical lesions on papanicolaou tests?
Samimi, SA, Mody, RR, Goodman, S, Luna, E, Armylagos, D, Schwartz, MR, Mody, DR & Ge, Y 2018, , Archives of Pathology and Laboratory Medicine, vol. 142, no. 3, pp. 347-352. https://doi.org/10.5858/arpa.2016-0478-OA

Programmed death ligand-1 (pd-l1) expression in either tumor cells or tumor-infiltrating immune cells correlates with solid and high-grade lung adenocarcinomas
Driver, BR, Miller, RA, Miller, T, Deavers, M, Gorman, B, Mody, D, Ge, Y, Barrios, R, Bernicker, E, Kim, M & Cagle, PT 2017, , Archives of Pathology and Laboratory Medicine, vol. 141, no. 11, pp. 1529-1532. https://doi.org/10.5858/arpa.2017-0028-OA

Cervical biopsy rates before and after the introduction of human papillomavirus type reporting in co-tests with negative cytology
Ruff, H, Mody, D, Luna, E, Armylagos, D & Thrall, MJ 2017, , Journal of the American Society of Cytopathology, vol. 6, no. 5, pp. 180-184. https://doi.org/10.1016/j.jasc.2017.06.005

Aberrant staining with Grocott's methenamine silver: utility beyond fungal organisms
Wright, AM, Mody, DR, Anton, RC & Schwartz, MR 2017, , Journal of the American Society of Cytopathology, vol. 6, no. 6, pp. 223-227. https://doi.org/10.1016/j.jasc.2017.05.004

Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer
Ge, Y, Christensen, P, Luna, E, Armylagos, D, Schwartz, MR & Mody, DR 2017, , Cancer cytopathology, vol. 125, no. 8, pp. 652-657. https://doi.org/10.1002/cncy.21875

Performance of Roche cobas high-risk human papillomavirus (hrHPV) testing in the two most common liquid-based Papanicolaou test platforms
Fuller, MY, Mody, RR, Luna, E, Armylagos, D, Schwartz, MR, Mody, DR & Ge, Y 2018, , Journal of the American Society of Cytopathology, vol. 7, no. 3, pp. 142-148. https://doi.org/10.1016/j.jasc.2017.10.003

Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions
Zhou, H, Mody, RR, Luna, E, Armylagos, D, Xu, J, Schwartz, MR, Mody, DR & Ge, Y 2016, , Cancer cytopathology, vol. 124, no. 5, pp. 317-323. https://doi.org/10.1002/cncy.21687

Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria
Driver, BR, Portier, BP, Mody, DR, Deavers, M, Bernicker, EH, Kim, MP, Teh, BS, Santacruz, JF, Kopas, L, Munden, RF & Cagle, PT 2016, , Archives of Pathology and Laboratory Medicine, vol. 140, no. 4, pp. 312-317. https://doi.org/10.5858/arpa.2015-0361-OA

Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions
Salazar, KL, Zhou, HS, Xu, J, Peterson, LE, Schwartz, MR, Mody, DR & Ge, Y 2015, , Acta Cytologica, vol. 59, no. 5, pp. 391-398. https://doi.org/10.1159/000442512